|
BE890819A
|
|
Pharmaceutical compositions based on alginic acid and tris- (hydroxymethyl) aminomethane
|
|
FR2514259A1
|
|
Compsn. contg. alginic acid and tris:hydroxymethyl-aminomethane - for treating hyperacidity, ulcers and gastritis
|
|
SE8105902L
|
|
Compsn. contg. alginic acid and tris:hydroxymethyl-aminomethane - for treating hyperacidity, ulcers and gastritis
|
|
DK440381A
|
|
Pharmaceutical products for the treatment of gastric hyperacidity, gastritis and gastroduodenal ulcus
|
|
NL8104523A
|
|
Compsn. contg. alginic acid and tris:hydroxymethyl-aminomethane - for treating hyperacidity, ulcers and gastritis
|
|
PH17690A
|
|
Pharmaceutical composition for the treatment of gastric hyperacidity gastritis and gastroduodenal ulcers
|
|
AU7598681A
|
|
Alginic acid and tri-(hydroxymethyl)amino-methane compositions
|
|
ZA8106799B
|
|
Pharmaceutical compositions for the treatment of gastric hyperacidity,gastritis and gastro-duodenal ulcers
|
|
DE3139133A1
|
|
PHARMACEUTICAL PREPARATIONS FOR TREATING GASTRIC HYPERACIDITY, GASTRITIS AND GASTRODUODENAL ULCERS
|
|
CA1176984A
|
|
Pharmaceutical compositions for the treatment of gastric hyperacidity, gastritis and gastroduodenal ulcers
|
|
PH17043A
|
|
A pharmaceutical composition for oral administration containing cytidin diphosphocholine
|
|
CA1171788A
|
|
Pharmaceutical composition for oral administration containing cytidin diphosphocholine
|
|
GB2074445A
|
|
Oral pharmaceutical compositions containing cytidine diphospholine
|
